Marex Group plc Buys Shares of 4,914 Agilent Technologies, Inc. $A

Marex Group plc bought a new stake in shares of Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 4,914 shares of the medical research company’s stock, valued at approximately $580,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in A. Ransom Advisory Ltd bought a new position in Agilent Technologies during the 1st quarter valued at $32,000. Central Pacific Bank Trust Division acquired a new position in Agilent Technologies in the second quarter worth about $33,000. State of Wyoming bought a new stake in Agilent Technologies in the second quarter valued at about $35,000. WFA of San Diego LLC acquired a new stake in Agilent Technologies during the second quarter valued at approximately $61,000. Finally, Ameritas Advisory Services LLC bought a new position in Agilent Technologies during the 2nd quarter worth approximately $64,000.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on A shares. Rothschild & Co Redburn assumed coverage on Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price target for the company. Morgan Stanley assumed coverage on shares of Agilent Technologies in a research note on Tuesday, December 2nd. They set an “overweight” rating for the company. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, October 3rd. The Goldman Sachs Group started coverage on shares of Agilent Technologies in a research report on Tuesday, December 9th. They set a “buy” rating and a $170.00 price objective for the company. Finally, TD Cowen increased their price objective on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research note on Tuesday, October 14th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $161.77.

Agilent Technologies Stock Down 2.3%

Agilent Technologies stock opened at $139.56 on Monday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The company has a 50-day simple moving average of $145.59 and a 200-day simple moving average of $129.27. The firm has a market capitalization of $39.57 billion, a P/E ratio of 30.54, a P/E/G ratio of 4.05 and a beta of 1.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The firm had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. During the same period last year, the firm posted $1.46 EPS. Agilent Technologies’s quarterly revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th will be issued a $0.255 dividend. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 21.66%.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of Agilent Technologies stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the sale, the vice president owned 31,846 shares of the company’s stock, valued at $4,935,811.54. The trade was a 8.61% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Padraig Mcdonnell sold 911 shares of the business’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total value of $130,491.64. Following the transaction, the chief executive officer owned 32,058 shares of the company’s stock, valued at $4,591,987.92. This trade represents a 2.76% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 16,401 shares of company stock worth $2,468,962.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.